文献速递产科母胎医学

子痫前期中的血小板计数:系统综述与Meta分析

Platelet count in preeclampsia: a systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-04-24

该系统综述与Meta分析纳入56项观察性研究,共4892例子痫前期孕妇和9947例血压正常孕妇,比较血小板计数。结果显示子痫前期患者血小板计数显著低于血压正常对照,且轻度和重度子痫前期、孕中晚期及诊断前均显著降低,但孕早期无显著差异。作者认为血小板计数可能是识别和预测子痫前期的潜在标志物。

要点

  • 子痫前期患者血小板计数较血压正常孕妇显著降低,总体平均差值为-32.83。
  • 轻度子痫前期平均差值为-18.65,重度子痫前期为-42.61。
  • 孕中期、孕晚期及诊断前血小板计数均显著降低,但孕早期无显著差异。

核心结论

  • 本Meta分析证实子痫前期孕妇血小板计数显著降低,无论严重程度及是否合并相关并发症,甚至在子痫前期发病前和孕中期即已降低。
  • 作者认为血小板计数可能是识别和预测子痫前期的潜在标志物。

研究设计与样本

  • 系统综述与Meta分析,检索Medline、Embase、ScienceDirect、Web of Science、Cochrane Library、NICHD-DASH、LILACS和Scopus从建库至2022年4月22日。
  • 纳入比较子痫前期孕妇与血压正常孕妇血小板计数的观察性研究,共56项研究,含4892例子痫前期孕妇和9947例血压正常孕妇。
  • 计算血小板计数的平均差值及95%置信区间,采用I²统计量评估异质性,并进行敏感性和亚组分析。
  • 使用RevMan 5.3和ProMeta 3软件进行统计分析。

主要发现

  • 子痫前期孕妇血小板计数显著低于血压正常对照:总体平均差值-32.83(95%CI -40.13至-25.52;P<.00001;I²=92%)。
  • 轻度子痫前期平均差值-18.65(95%CI -27.17至-10.14;P<.00001;I²=84%),重度子痫前期平均差值-42.61(95%CI -57.53至-27.68;P<.00001;I²=94%)。
  • 孕中期平均差值-28.84(95%CI -44.59至-13.08;P=.0003;I²=93%),孕晚期平均差值-40.67(95%CI -52.14至-29.20;P<.00001;I²=92%),诊断子痫前期前平均差值-18.81(95%CI -29.98至-7.64;P=.009;I²=87%)。
  • 孕早期平均差值-15.14(95%CI -37.71至7.43;P=.19;I²=71%),无显著差异。
  • 合并敏感度0.71,特异度0.77,曲线下面积0.80。

关键数值与推荐

  • 子痫前期孕妇血小板计数较血压正常孕妇总体平均差值-32.83(95%CI -40.13至-25.52;P<.00001;I²=92%)。
  • 轻度子痫前期平均差值-18.65(95%CI -27.17至-10.14;P<.00001;I²=84%),重度子痫前期平均差值-42.61(95%CI -57.53至-27.68;P<.00001;I²=94%)。
  • 孕中期平均差值-28.84(95%CI -44.59至-13.08;P=.0003;I²=93%),孕晚期平均差值-40.67(95%CI -52.14至-29.20;P<.00001;I²=92%),诊断前平均差值-18.81(95%CI -29.98至-7.64;P=.009;I²=87%),孕早期平均差值-15.14(95%CI -37.71至7.43;P=.19;I²=71%)。
  • 合并敏感度0.71,特异度0.77,曲线下面积0.80。

临床怎么用

  • 作者认为血小板计数可能是识别和预测子痫前期的潜在标志物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Many studies have reported the association between platelets and preeclampsia. However, sample sizes were small, and their findings were inconsistent. We conducted a systematic review and meta-analysis to evaluate the association in pooled samples and in detail. DATA SOURCES: A systematic literature search was performed using Medline, Embase, ScienceDirect, Web of Science, Cochrane Library, NICHD-DASH, LILACS, and Scopus from inception to April 22, 2022. STUDY ELIGIBILITY CRITERIA: Observational studies comparing platelet count between women with preeclampsia and normotensive pregnant women were included. METHODS: The mean differences with 95% confidence interval in platelet count were calculated. Heterogeneity was assessed using I2 statistics. Sensitivity and subgroup analyses were conducted. Statistical analysis was performed using RevMan 5.3 and ProMeta 3 software. RESULTS: A total of 56 studies comprising 4892 preeclamptic and 9947 normotensive pregnant women were included. Meta-analysis showed that platelet count was significantly lower in women with preeclampsia than in normotensive controls (overall: mean difference, -32.83; 95% confidence interval, -40.13 to -25.52; P<.00001; I2=92%; mild preeclampsia: mean difference, -18.65; 95% confidence interval, -27.17 to -10.14; P<.00001; I2=84%; severe preeclampsia: mean difference, -42.61; 95% confidence interval, -57.53 to -27.68; P<.00001; I2=94%). Significantly lower platelet count was also observed in the second trimester (mean difference, -28.84; 95% confidence interval, -44.59 to -13.08; P=.0003; I2=93%), third trimester (mean difference, -40.67; 95% confidence interval, -52.14 to -29.20; P<.00001; I2=92%), and before the diagnosis of preeclampsia (mean difference, -18.81; 95% confidence interval, -29.98 to -7.64; P=.009; I2=87%), but not in the first trimester (mean difference, -15.14; 95% confidence interval, -37.71 to 7.43; P=.19; I2=71%). Overall, the pooled sensitivity and specificity of platelet count were 0.71 and 0.77, respectively. The area under the curve was 0.80. CONCLUSION: This meta-analysis confirmed that platelet count was significantly lower in preeclamptic women, irrespective of severity and presence or absence of associated complications, even before the onset of preeclampsia and in the second trimester of pregnancy. Our findings suggest that platelet count may be a potential marker to identify and predict preeclampsia.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Woldeamanuel GG, Tlaye KG, Wu L, et al. Platelet count in preeclampsia: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023. PMID: 37098392. doi:10.1016/j.ajogmf.2023.100979

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。